Clinical Features	Time to Death		YEARS_TO_BIRTH		PATHOLOGIC_STAGE		PATHOLOGY_T_STAGE		PATHOLOGY_M_STAGE		GENDER		RADIATION_THERAPY	
	nMutated (%)	nWild-Type	logrank test_P	logrank test_Q	Wilcoxon-test_P	Wilcoxon-test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q
GNAQ	40 (50%)	40	0.16106	1	0.46728	1	0.00166	0.093	0.80081	1	0.051458	0.823	1	1	0.61532	1
GNA11	36 (45%)	44	0.42289	1	0.74948	1	0.058799	0.823	0.83602	1	0.30738	1	0.65284	1	0.082765	0.907
EIF1AX	10 (12%)	70	0.34761	1	0.41917	1	1	1	0.66782	1	1	1	0.3197	1	1	1
SF3B1	18 (22%)	62	0.097208	0.907	0.23056	1	0.88242	1	0.87827	1	0.57284	1	0.59646	1	0.54489	1
PRMT8	5 (6%)	75	0.37472	1	0.13323	0.933	0.11492	0.919	0.39072	1	1	1	0.64879	1	0.18026	1
CYSLTR2	3 (4%)	77	0.47161	1	0.42477	1	0.68577	1	0.77962	1	1	1	1	1	1	1
BAP1	12 (15%)	68	0.69451	1	0.055569	0.823	0.23249	1	0.91582	1	1	1	1	1	0.39421	1
SFRS2	3 (4%)	77	0.55447	1	0.70389	1	1	1	0.57598	1	1	1	1	1	1	1